22/03/21

Cumulus Oncology launches partnership with Lead Discovery Center GmbH – an exciting next chapter for this pioneering Eos portfolio company

04/03/21

ClinSpec Diagnostics Limited (ClinSpec Dx) reaches its round two funding target of £3.5 million from Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders.

17/02/21

Eos portfolio Cumulus Oncology eyes further growth as US office is set to open this year

15/02/21

Eos launches trans-Atlantic Venture partnership with Kineticos Disruptor Fund

25/01/21

Chris Brinsmead CBE joins the Eos partnership

20/01/21

Scotland gets top marks for producing University spin outs

18/01/21

Digital Sports Arena (DSA) signs global publishing deal with Playstack

05/01/21

‘Lab on a chip’ technology company RAB Microfluidics completes £1.24 million investment round lead by Eos Advisory

01/12/20

ILC Therapeutics announces significant and first international investor Medical Incubator Japan (MIJ) in a round that includes further investment from Eos

27/11/20

Mark Beaumont joins the Eos executive leadership team

25/11/20

Edinburgh based Cumulus Oncology appoints Nicola Broughton, Chris Brinsmead, Mohamed Raza (Raz) Dewji and Ian Waddell to their advisory board

18/11/20

M&S and Eos portfolio business 3F BIO collaborate for mycoprotein vegan range

15/09/20

Eos portfolio business ClinSpec DX focused on the early detection of cancer has received a major seven-figure funding injection

15/09/20

Eos portfolio business ClinSpec DX secures a further £2.4m in Funding for Early Cancer Detection Tech

15/09/20

Eos portfolio business, the cancer drug discovery accelerator Cumulus Oncology, launches its first spinout – Modulus Oncology